ALPHA TEKNOVA, INC. (TKNO) Current Ratio
- Current ratio · latest quarter: Value 4.49×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 4.49× | Current assets / current liabilities. $30.82M ÷ $6.87M ≈ 4.49× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 30.82M USD | Assets, Current |
| Current obligations | 6.87M USD | Liabilities, Current |
| Cash and equivalents | 6.00M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current |
| Customer receivables | 5.41M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 6.91M USD | Inventory, Net |
| Payables | 1.44M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $30.82M | $6.87M | $6.00M | (m) | $5.41M | $6.91M | $1.44M | (m) | 4.49× |
| 2026-03-31 | $31.67M | $6.90M | $4.31M | (m) | $5.67M | $6.87M | $1.62M | (m) | 4.59× |
| 2025-12-31 | $34.51M | $7.54M | $5.91M | (m) | $4.62M | $7.05M | $1.38M | (m) | 4.58× |
| 2025-09-30 | $36.56M | $6.94M | $3.20M | (m) | $5.13M | $6.91M | $1.08M | $0.00 | 5.27× |
| 2025-06-30 | $38.06M | $6.48M | $3.28M | (m) | $5.14M | $7.61M | $1.20M | $0.00 | 5.87× |
| 2025-03-31 | $39.73M | $7.04M | $3.38M | (m) | $5.62M | $6.57M | $1.55M | $0.00 | 5.64× |
| 2024-12-31 | $42.78M | $11.21M | $3.71M | (m) | $4.31M | $6.80M | $825.00K | $4.04M | 3.82× |
| 2024-09-30 | $45.93M | $9.72M | $6.14M | (m) | $4.61M | $7.67M | $975.00K | $2.53M | 4.73× |
| 2024-06-30 | $35.28M | $7.41M | $18.60M | (m) | $4.60M | $10.99M | $1.02M | $1.01M | 4.76× |
| 2024-03-31 | $38.82M | $7.04M | $21.60M | (m) | $4.56M | $11.21M | $1.54M | (m) | 5.52× |
| 2023-12-31 | $45.66M | $8.88M | $28.48M | (m) | $3.95M | $11.59M | $1.49M | $0.00 | 5.14× |
| 2023-09-30 | $51.08M | $8.34M | $32.08M | (m) | $5.16M | $11.47M | $1.42M | (m) | 6.13× |
| 2023-06-30 | $43.11M | $28.65M | $23.71M | (m) | $4.57M | $12.02M | $1.08M | $22.16M | 1.50× |
| 2023-03-31 | $49.63M | $8.65M | (m) | (m) | $4.78M | $12.15M | $1.89M | (m) | 5.74× |
| 2022-12-31 | $61.14M | $10.88M | $42.24M | (m) | $4.26M | $12.25M | $2.45M | (m) | 5.62× |
| 2022-09-30 | $70.07M | $12.33M | (m) | (m) | $5.58M | $10.32M | $3.48M | (m) | 5.68× |
| 2022-06-30 | $80.27M | $11.87M | (m) | (m) | $5.81M | $7.91M | $1.42M | (m) | 6.77× |
| 2022-03-31 | $91.94M | $12.64M | (m) | (m) | $5.98M | $6.43M | $3.03M | (m) | 7.28× |
| 2021-12-31 | $101.20M | $7.74M | (m) | (m) | $4.67M | $5.39M | $2.25M | (m) | 13.07× |
| 2021-09-30 | $111.08M | $6.20M | $98.01M | $0.00 | $4.56M | $4.40M | $3.32M | (m) | 17.90× |
| 2021-06-30 | $118.32M | $5.94M | $108.02M | $0.00 | $4.06M | $3.88M | $2.64M | (m) | 19.92× |
| 2020-12-31 | $16.41M | $3.96M | $3.31M | $1.81M | $4.62M | $3.58M | $1.64M | (m) | 4.14× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |